Skip to main content
. 2022 Jul 8;10(3):e33755. doi: 10.2196/33755

Table 2.

Demographic characteristics of 4 subgroups of the stroke survivors.

Variables CNVRa subgroup (n=17) CIVRb subgroup (n=14) CNCGc subgroup (n=15) CICGd subgroup (n=11) ANOVAe (treatment) ANOVA (cognitive) ANOVA (treatment × cognitive) Chi-square test





F 1,53 P value F 1,53 P value F 1,53 P value χ 2 3 P value
Age (years), mean (SD) 57.29 (11.08) 62.57 (9.57) 54.40 (10.37) 65.55 (10.40) <0.001 .99 8.653 .005 1.105 .30

Disease duration (days), mean (SD) 36.47 (36.99) 51.86 (43.88) 28.80 (14.32) 32.00 (16.57) 2.656 .11 1.211 .28 0.521 .47

MMSEf, mean (SD) 28.71 (1.05) 21.21 (4.06) 28.60 (1.12) 20.09 (4.57) 0.607 .44 102.844 <.001 0.416 .52

NIHSSg, mean (SD) 5.35 (2.55) 9.21 (2.86) 6.87 (3.25) 6.18 (3.37) 0.901 .35 3.940 .052 8.070 .006h,i

Sex (female/male), n 2/15 4/10 5/10 3/8





2.291 .54
Hemiplegic side (right/left), n 7/10 6/8 6/9 8/3





3.540 .32
Brunnstrom stage of arm (stage 1-6), n 1/5/4/3/3/1 4/6/4/0/0/0 1/10/1/2/1/0 1/3/2/1/3/1





18.683 .23
Brunnstrom stage of hand (stage 1-6), n 0/9/0/4/3/1 5/7/2/0/0/0 2/9/2/0/2/0 3/2/0/2/3/1





25.014 .050

aCNVR: cognitive normal virtual reality group.

bCIVR: cognitive impaired virtual reality group.

cCNCG: cognitive normal control group.

dCICG: cognitive impaired control group.

eANOVA: analysis of variance.

fMMSE: Mini-Mental State Examination.

gNIHSS: National Institute of Health Stroke Scale.

hANOVA result was significant.

iBonferroni post hoc test was significant between the CNVR subgroup and the CIVR subgroup (P=.004).